Compare Adecoagro SA (AGRO) vs Cassava Sciences Inc (FLNA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Adecoagro SA vs Cassava Sciences Inc — how do they compare? Adecoagro SA trades at $9.67 (market cap $1.39B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Adecoagro SA is far larger — about 29.1× Cassava Sciences Inc's market cap, and Adecoagro SA pays a 3.07% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| AGRO | FLNA | |
|---|---|---|
Market Cap | $1.39B | $47.75M |
Sector | Technology | Health |
52-Week High | $15.25 | $4.64 |
52-Week Low | $7.13 | $0.87 |
Enterprise Value | $3.43B | -$34.93M |
Dividend Yield | 3.07% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AGRO trades at $9.45, up 0.96% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported negative net income of -$8.35M for 2025 despite $1.43B revenue, though 2026 projections show potential profitability improvement. Recent acquisition of Caarapó Mill expands operational footprint while analyst consensus leans neutral with 50% hold ratings.
Outlook remains cautious with elevated P/E ratio of 536.67 offset by attractive P/B of 0.79. Key risks include commodity volatility and integration challenges from recent acquisitions. The stock presents value opportunity if 2026 profitability targets are achieved, but requires careful monitoring of earnings trajectory.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Adecoagro SA
Adecoagro is a South American agricultural company. It operates a diversified business including farming crops, rice, and dairy, as well as producing sugar, ethanol, and renewable energy from its industrial facilities.
Read more on AGRO →About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →
